| 000 | 01584 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517113400.0 | ||
| 264 | 0 | _c20170707 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.2016.146381 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMendes, Rui D | |
| 245 | 0 | 0 |
_aThe relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bHaematologica _c09 2016 |
||
| 300 |
_a1010-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPTEN Phosphohydrolase _xgenetics |
| 650 | 0 | 4 |
_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Notch1 _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aCanté-Barrett, Kirsten | |
| 700 | 1 | _aPieters, Rob | |
| 700 | 1 | _aMeijerink, Jules P P | |
| 773 | 0 |
_tHaematologica _gvol. 101 _gno. 9 _gp. 1010-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2016.146381 _zAvailable from publisher's website |
| 999 |
_c26379569 _d26379569 |
||